Recalled Medicines & supplements – Current GIS Alerts 2026
Found 698 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Menaright Forte, Phytomenadion Injection 2mg/0,2 ml
The glass container shatters when opened, leaving glass fragments in the fingers and inside the ampoule, and differences in the solution volume in ampoules were found. Potential effects: injuries, glass foreign bodies, complications after injection, incorrect drug dose, life‑threatening events.
tianDe Phytotea with Angelica Sinensis and Salvia, 60g
Chlorpyrifos detected – pesticide residue exceeding the permissible level; substance harmful to health. Potential effects: poisoning, neurological disorders.
Heviran
A quality defect was found consisting in placing, in some packs of Heviran 400 mg film-coated tablets, a package leaflet in Lithuanian intended for Furosemid Polpharma 40 mg tablets. Potential effects: improper use of the medicine, lack of correct information on dosage, adverse reactions and precautions.
Amiodaron Hameln
Increased crystallization of the product was found in the concentrate for solution for injection or infusion, which may affect the safety and efficacy of intravenous administration. Potential effects: vascular embolism, lack of treatment efficacy, intravenous complications.
Vitaminum C Teva
A result outside specification limits was found for the parameter particles visible to the naked eye in an intramuscular or intravenous injection solution, which may pose a direct risk to patients’ health or life. Potential effects: embolism, inflammatory reactions, circulatory complications.
Tadalafil Aristo
It cannot be excluded that keeping this medicinal product on the market may pose a risk to patient health, due to identified non-compliances with Good Manufacturing Practice at one manufacturer and the possibility of a quality defect. Potential effects: risk to patient health, possible lack of efficacy or other treatment complications.
Tadalafil Aristo
Non-compliance with Good Manufacturing Practice was found at one of the manufacturers, resulting in suspension of the GMP certificate, so it cannot be excluded that keeping the product on the market may pose a risk to patient health. Potential effects: possible risk to patient health, including lack of treatment efficacy or unpredictable adverse effects.
Structum
Out-of-specification results were found for the TAMC parameter (total aerobic microbial count) and the presence or probability of occurrence of Bacillus cereus was demonstrated. Potential effects: bacterial infection, gastrointestinal symptoms, possible intoxication.
Angusta
Given that the cause of the out-of-specification result for an unknown impurity and its impact on the product quality and safety of use are currently unknown, it cannot be ruled out that keeping this product on the market may pose a threat to patient health. Potential effects: threat to patient health.
Lactulose-MIP
A risk of microbiological contamination of the active substance used to produce the syrup was identified, resulting in a quality defect of the product and a potential direct threat to patients’ health or life. Potential effects: infection, complications, health risk.
Lactulose-MIP
A risk of microbiological contamination of the active substance used to manufacture the medicinal product was reported, creating a potential threat to patients' health. Potential effects: infections, complications, lack of treatment safety.
Sumilar HCT
Capsules with an abnormal appearance and colour were identified inside the blister, which constitutes a suspected quality defect of the medicinal product and a potential risk to patients’ health or life. Potential effects: lack of certainty regarding treatment efficacy and safety.
Hemkortin-HC
An error was found in the printed strength of the active substances on the immediate packaging, affecting some tubes in batch D0222, which may lead to incorrect use of the medicine. Potential effects: improper dosing, risk of adverse reactions or lack of treatment efficacy.
Accupro 40
The letter concerned a request for a decision to withdraw the specified batches of medicinal products from the market due to the presence of contamination (N-nitroso-quinapril) above the permitted daily intake limit. Potential effects: possible carcinogenic effects, organ damage, complications of hypertension therapy.
Accupro 10
detection of contamination (N-nitroso-quinapril) above the acceptable daily intake limit. Potential effects: possible carcinogenic effect and increased risk of adverse reactions.
Accupro 5
due to the detected presence of contamination (N-nitroso-quinapril) above the acceptable daily intake limit. Potential effects: possible carcinogenic or toxic effects and a health risk for patients.
Vigantol
Suspected quality defect of the medicinal product resulting from the use of an excipient linked to a batch with an out-of-specification active substance content, which may lead to incorrect dosing of vitamin D. Potential effects: lack of efficacy or adverse effects related to overdose.
Accupro 20
the presence of the impurity (N-nitroso-quinapril) above the acceptable daily intake limit. Potential effects: increased risk of toxicity and carcinogenic effects, especially during long-term use.
NETSPOT
A quality defect of the NETSPOT product was identified – stability test results showed the content of the active substance DOTATATE close to the lower limit of the specification, meaning that established quality requirements are not met. Potential effects: lack of diagnostic efficacy, risk of delayed disease diagnosis.
Biotrakson
An out-of-specification result for the endotoxin parameter was found in archival samples of an injectable product, which may pose a real and highly probable risk to patients’ health or life. Potential effects: poisoning, severe systemic reactions, septic complications.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.